Enhanced motivation to alcohol in transgenic mice expressing human α-synuclein.
Carola RotermundGustavo K ReolonSarah LeixnerCindy BodenAinhoa BilbaoPhilipp J KahlePublished in: Journal of neurochemistry (2017)
α-Synuclein (αSYN) is the neuropathological hallmark protein of Parkinson's disease (PD) and related neurodegenerative disorders. Moreover, the gene encoding αSYN (SNCA) is a major genetic contributor to PD. Interestingly, independent genome-wide association studies also identified SNCA as the most important candidate gene for alcoholism. Furthermore, single-nucleotide-polymorphisms have been associated with alcohol-craving behavior and alcohol-craving patients showed augmented αSYN expression in blood. To investigate the effect of αSYN on the addictive properties of chronic alcohol use, we examined consumption, motivation, and seeking responses induced by environmental stimuli and relapse behavior in transgenic mice expressing the human mutant [A30P]αSYN throughout the brain. The primary reinforcing effects of alcohol under operant self-administration conditions were increased, while consumption and the alcohol deprivation effect were not altered in the transgenic mice. The same mice were subjected to immunohistochemical measurements of immediate-early gene inductions in brain regions involved in addiction-related behaviors. Acute ethanol injection enhanced immunostaining for the phosphorylated form of cAMP response element binding protein in both amygdala and nucleus accumbens of αSYN transgenic mice, while in wild-type mice no effect was visible. However, at the same time, levels of cFos remain unchanged in both genotypes. These results provide experimental confirmation of SNCA as a candidate gene for alcoholism in addition to its known link to PD.
Keyphrases
- wild type
- binding protein
- copy number
- genome wide
- endothelial cells
- alcohol consumption
- resting state
- genome wide identification
- end stage renal disease
- functional connectivity
- genome wide association
- drug induced
- newly diagnosed
- white matter
- mental health
- liver failure
- gene expression
- type diabetes
- climate change
- dna methylation
- pluripotent stem cells
- small molecule
- adipose tissue
- hepatitis b virus
- blood brain barrier
- patient reported outcomes
- cerebral ischemia
- metabolic syndrome
- multiple sclerosis
- genome wide analysis
- respiratory failure
- risk assessment
- protein protein
- virtual reality